Blood test may spot lung cancer early

NCT ID NCT07182214

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is looking at whether a blood test (called a liquid biopsy) can help detect lung cancer. Researchers will collect blood samples from 1,340 people, some with lung nodules and some without, to measure specific molecules called miRNA and DNA methylation. The goal is to see if these markers can tell the difference between people who have lung cancer and those who don't.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple blood test to help detect lung cancer earlier, potentially improving outcomes.

What could go wrong

This is an early observational study, not a treatment trial. It may not prove the test is accurate enough for widespread use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Pharus Taiwan, Inc.

    RECRUITING

    Hsinchu, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••